5 курс / Пульмонология и фтизиатрия / Бронхолегочные_осложнения_хронического_лимфолейкоза_и_множественной

ные болезни легких // Рус. мед. журн. – 2001. – Т. 9, № 1. – С. 9–

32.

256.Чучалин А.Г. Клинические рекомендации по хронической обструктивной болезни легких. – М., 2001. – 39 с.

257.Чучалин А.Г., Синопальников А. И., Чернеховская Н. Е. Пневмония. – М. : Экономика и информатика, 2002. – 479 с.

258.Чучалин А.Г., Котляров А.П., Георгиади С.Г. Рентгенография и компьютерная томография в диагностике различных видов идиопатических интерстициальных пневмоний // Пульмонология. – 2003. – № 2. – С. 89–96.

259.Чучалин А.Г. Белая книга. Пульмонология // Пульмонология. – 2004. – № 1. – С. 7–34.

260.Чучалин А.Г. Диагностика респираторных заболеваний. Анамнез и физикальное обследование // Респираторная медицина : рук. для врачей. – М.: ГЭОТАР-Медиа, 2007. Т.1. – С. 231 – 237.

261.Чучалин, А. Г. Хроническая обструктивная болезнь легких и сопутствующие заболевания // Пульмонология. – 2008. – № 2.

–С. 5 – 14.

262.Чучалин А.Г. Хроническая обструктивная болезнь легких. – М.: издательский дом «АТМОСФЕРА», 2008. – 567 с.

263.Шнейдер Т.В., Симкин С.М., Беккер О.М. Трудности диагностики лимфогранулематоза у больной с преимущественным поражением легких // Новые Санкт-Петербургские врачебные ведомости. – 2008. – № 2. – С. 94 – 97.

264.Шойхет Я.Н., Беднаржевская Т.В., Лукьяненко Н.Я. Диагностика легочной гипертензии у больных хроническими заболеваниями легких // Пульмонология. – 2004. – № 3. – С. 64–67.

265.Шойхет Я.Н., Клестер Е.Б. Клинико-функциональные нарушения сердечно-сосудистой системы у пациентов с хронической обструктивной болезнью легких при наличии хронической сердечной недостаточности // Пульмонология. – 2008. – № 3. – С. 62 –

67.

266.Яблонский П.К., Николаев Г.В., Решетов А.В Патология грудной стенки // Респираторная медицина : рук. для врачей / под. ред. А.Г. Чучалина. – М.: ГЭОТАР-Медиа, 2007. Т.2. – С. 638 – 651.

267.Pulmonary complications in chronic lymphocytic leukemia / S. Ahmed [et al.] // Conference / American Thoracic Society. – Seattle, Washington, 16 May 2003.

291

268.Anaissie E.J., Fainstein V., Bodey G.P. Randomizes trial of beta-lactam regimens in febrile neutropenic cancer patients // Am. J. Ved.

–1988. – Vol. 27. – P. 470–476.

269.Anderson K.C., Kyle R.A. Recent advances in the biology and treatment of multiple myeloma // Amer. Soc. Hematol. – 1998. – 1999. – P. 63–88.

270.Anderson K.S. Targeted therapy for multiple myeloma // Semin. Haematol. – 2001. – Vol. 38. – P. 289–294.

271.Anderson K.S. Novel therapies. Revimid (CC-5031) // Myeloma Focus. Neus-litter of the Multiple myeloma research Foundation. – 2002. – Vol. 4. – P. 3.

272.Arbo M. D. J., Snudman D.R. Monotherapy is appropriate for nosocomial pneumonia in the intensive care unit // Semin. Resp. Dis.

–1993. – Vol. 8. – P. 259–267.

273.Arvan S. Echocardiography. – New York, 1984. – P. 513.

274.Attal M., Harousseau J.L. Standard therapy versus autologous transplantation in multiple myeloma // Hematol. / Oncology. Clin. N. Amer. – 1997. – N 11. – Р. 133–144.

275.Multiple myeloma with pleural involvement / P. Badrinas [et al.] // Amer. Rev. Resp. Dis. – 1974. – Vol. 110, N 1. – P. 82–87.

276.High-resolution CT in chronic pulmonary changes after

mustard gas exposure / Af. H. Bagheri [et al.] // Acta radiological. – 2003. – Vol. 44. – P. 241–245.

277.Bannerji R., Kitada S., Flinn I.W. Apoptotic regulatory and complement-protecting protein expression in chronic lymphocytic leukemia // J. Clin. Oncol. – 2003. – Vol. 21. – P. 1466–1471.

278.Ball P. Epidemiology and treatment of chronic bronchitis and its exacerbations // Chest. – 1995. – Vol. 108, N 2. – Р. 43–52.

279.Barnaud G., Deschamps C., Manceron V. Brain abscess

caused by Nocardia cyriacigeorgia in patient with human immunodeficiency virus infection // J. Clin. Microbiol. – 2005. – Vol. 45. – P. 158– 164.

280.Batata A., Shen B. Immunophenotyping of subtypes of B- chronic (mature) Lymphoid leukemia. A study of 242 cases // Cancer. – 1992. – Vol. 1570, N 10, Nov. – Р. 2436–2443.

281.Bayer-Garner I. B., Smoller B.R. Al amyloidosis is not present as an incidental finding in cutaneous biopsies of patients with

292

multiple mieloma // Clin. Exp. Dermatol. – 2002. – Vol. 27. – P. 240– 242.

282.Belmonte K. F. Cholinergic pathways in the lungs and anticholinergic therapy for chronic obstructive pulmonary disease // Proc. Am. Thorac. Soc. – 2005. – № 2. – P. 297–304.

283.Bennet J. M., Auqer A., Dighiero G. A new prognostic classification of chronic lymphocytic leukemia derived from multivariant survival analysis // Cancer. – 1981. – N 48. – P. 198–206.

284.Bennet, J. M. The use of CHOP in the treatment of CLL // Brit. J. Haematol. – 1990. – Vol. 74, N 4. – Р. 546–549.

285.Pulmonary involvement as the major manifestation of chronic lymphocytic leukemia / N. Berkman [et al.] // Leuk. Lymphoma. – 1992.– Vol. 8, N 6. – P. 495–499.

286.Besznyad J., Balogh A., Hindy J. Solitares plasmozytom der Thoraxwand // Prax. Pnoum. – 1975. – Bd. 29, N 10. – S. 575–579.

287.Bjorkstrand B., Rasmussen T., Remes K. Feasibility of fludarabine added to VAD during induction therapy in multiple myeloma: a randomized phase II-stady // Eur. J. Haematol. – 2003. – Vol. 70. – P. 379–8383.

288.Bodey J.P., Bueltmann B., Duguid W. An international autopsy survey // Eur. J. Microbiol. Infekt. Dis. – 1992. – Vol. 15. – P. 99– 109.

289.Boedeker K.I., McNitt-Gray M.F., Rogers S.R. Emphysema: Effect of reconstruction algorithm on CT imaging measures // Radiology.

–2004. – Vol. 232, N 1. – P. 295–301.

290.Bonnet R. Growing group of extended-spectrum β- lactamases: the CTX-M enzymes // Antimicrob. Agents Chemot. – 2004.

–Vol. 48. – P. 1–14.

291.Brodeur F.G., Kazerooni E.A. Metastatic pulmonary calcification mimicking air-space disease. Technetium-99m-MDP SPECT imaging // Chest. – 1994. – Vol. 106, N 2. – P. 620–622.

292.Buhler S., Laitinen K., Holthofer H. High rate of monoclonal gammopathy among immunocompetent subjects with primary cytomegalovirus infection // Clin. Infect. Dis. – 2002. – Vol. 35. – P. 1430– 1433.

293

293. Byrd J.C., Peterson B.L., Morriton V.L. Randomized phase 2 study of fludarabine with concurrent versus sequential treatment with rituximab in symptomatic, untreated patients with B-cell chronic lymphocytik leukemia: results from Cancer and Leukemia Group B 9712 (CALGB 9712) // Blood. – 2003. – N 101. – P. 6–14.

294. Immunologic study of lymphoproliferative diseases / M.E. Cabrera [et al.] // Rev. Med. Chil. – 1992. – Vol. 120, N 7. – P. 772–777.

295.Callerame M.L., Madel M. Prunmocystic carinii pneumonia in two adults with multiple mieloma // Amer. J. Clin. Path. – 1966. – Vol. 45, N 3. – P. 258–263.

296.Сandoli A., Mestroni R., Damiani D. Caspofungin as first line therapy of pulmonary invasive fungal infection in 32 immunocompromised patients with hematologic malignancies // Eur. J. Haematol. – 2005. – Vol. 75, N 3. – P. 227–335.

297.Catovsky D., Foa R. The lymphoid leucaemias. – London,

1990.

298.Catovsky D. Chronic lymphoproliferative disorders // Curr. Opin. Oncol. – 1995. – Vol. 7, N 1, Jan. – P. 3–11.

299.Coxson H.O., Rogers R.M., Whittall K.P. A quantification of lung surface area in emphysema using computed tomography // Am. J. Respir. Crit. Care Med. – 1999. – Vol. 159. – P. 851–857.

300.Chen A., Sobel J.D. Emerging azole antifungals // Expert. Opin. Emerg. Drugs. – 2005. – Vol. 10, N 1. – P. 21–33.

301.Cheson B.D., Bennet J.M., M. Grever National Cancer Institute – sponsored Working Group guidelines for chronic lymphocytik leukemia: revised guidelines for diagnosis and treatment // Blood. – 1996. – Vol. 87, N 12. – P. 4990–4997.

302.Dabestani A., Mahan G., Takenaka Estimation of pulmonary wedge pressure from pulmonary artery dopler flow recordings // JACC. – 1985. – Vol. 5, N 2. – P. 500.

303.De Simone V., Leonardo E., Mancuso M. Maggi il plasmocitoma solitario del polmone. Considerarioni anotomo-cliniche su di I caso // Minerva chir. – 1980. – Vol. 35, N 17. – P. 1245–1250.

304.Devald G.W., Brockman S.R., Paternosten S.F. Cromosome anomalies detectad by interphase fluorescence in situ hybridization: correlation with significant biological features of B-cell chronic lymphocytik leukemia // Br. J. Haematol. – 2003. – Vol. 121. – P. 287–295.

294

305.Dierlamm T., Laack E., Dierlamm J. Ig M myeloma: a report of four cases // Ann. Hematol. – 2002. – Vol. 81. – P. 136–139.

306.Di Gaetano N., Gitteria E., Nota R. Complement activation determines R.the therapeutic activity of rituximab in vivo // J. Immunol. – 2003. – Vol. 171. – P. 1581–1587.

307.Dignani M., Anaissie E. Human fusariosis // Clin. Microbiol. Infect. – 2004. – Vol. 10. – P. 67–75.

308.Dool D.C., Ringenberg Q.S., Varbro J.W. Vascular Toxicity Associated with Antineoplastic Agents // J. Clin. Oncol. – 1986. – Vol. 4, N 9. – P. 1405–1417.

309.Dreger P., Brand R., Hansz J. Treatment-related mortally and graft-versus-leukemia activity after allogeneic shem cell transplantation for chronic lymphocytik leukemia using intensity-reduced conditioning // Leukemia. – 2003. – Vol. 17. – P. 841–848.

310.Durie B. G. M., Salmon S.E. A clinical staging system for multiple myeloma: Correlation of measured myeloma cell mass with presenting clinical features, response to treatment and survival // Cancer.

–1975. – Vol. 36, N 3. – P. 842–854.

311.Eichhorst B.F., Bush R., Hopfinger G. German CLL Study Group. Fludarabine plus cyclophosphamide versus fludarabine alone in fist-line theraphy of younger patients with chronic lymphocytik leukemia // Blood. – 2006. –Vol. 107, N 3. – P. 885–891.

312.Elter T., Borchmann P., Reiser M. Development of a new, four-weekly schedule (FluCam) with concomitant application of Campath1H and fludarabine in patients with relapsed/refractory CLL // Blood. – 2003. – Vol. 22. – P. 580.

313.Elter T., Borchmann P., Schulz H. Fludarabin in combination with alemtuzumab is effective and feasible in patients with relapsed or refractory B-cell chronic lymphocytik leukemia: results of a phase II trial // J. Clin. Oncol. – 2005. – Vol. 23. – P. 1–8.

314.Ely S.A. Diagnosis and management of multiple myeloma // Br. J. Haematol. – 2002. – Vol. 118. – P. 1194–1195.

315.Ferrajoly A.D., Thomas M. A. Albitar Alemtuzumab for minimal residual disease in CLL // Blood. – 2003. – Vol. 22. – P. 569.

316.Fonseaca R., Price-Troska T., Blood E. Implication of N-ras and K-ras mutation in clinical outcome and biology of multiple myeloma // Blood. – 2003. – P. 102 – 113.

317.Fonseaca R., Blood E., Rue M. Clinical and biologic implications of recurrent genomic aberrations in myeloma // Blood. – 2003. –

295

P.4569 – 4575.

318.Friedenberg W. R., Craham D., Greipp P. The treatment of multiple myeloma with docetaxel (an ECOG study) // Leuk. Res. – 2003.

– Vol. 27. – P. 751–754.

319.Gale K. Intensive Therapy Improves Survival in Patients With Multiple Myeloma // N. Engl. J. Med. – 2003. – Vol. 348. – P. 1875–1883.

320. Pulmonale Hypertonic chronic obstructive ventilation / A. Gassner [et al.] // Schweiz. Med. Wschr. – 1985. – Bd. 115, N 8. – S. 266–272.

321.Gevenois P.A., Yernault J.C. Can computed tomography quantify pulmonary emphysema? // Eur. Respir. J. – 1995. – Vol. 8. – P. 843–851.

322.Global strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonaru Disease. Gold Executive summaru / Klaus F. Rabe [et al.] // American jornal of Respiratory and Critical Care Medicine. – 2007. – vol. 176. – P. 532 – 555.

323.Greenlee R.T., Hill-Harmon M.B., T. Murray Cancer statistics 2001 // C.A. Cancer J. Clin. – 2001. – Vol. 51. – Р. 15–36.

324.Hainsworth J.D., Litchy S., Barton J.H. Singleagent rituximab as a fist-line and maintenance treatment for patient with chronic lymphocytic leukemia or small lymphocytic lumphoma: a phase II trial of the Minnie Pearl Cancer Research Notwork // J. Clin. Oncol. – 2003. – Vol. 21. – P. 1746–1751.

325.Hamer J. P. M. Practical echocardiography in the adult with Doppler and color-Doppler flow imaging. – London, 1990.

326.Hedenus M., Adriansson M., San Miguel J. Efficacy and safety of darbepoetin alfa in anaemic patients with lymphoproliferative malignancies: a randomized, doublebling, placebo-controlled study // Br. J. Haematol. – 2003. – Vol. 122, N 3. – P. 394–403.

327.Advences in biology of multiple myeloma: clinical aplications / T. Hideshima [et al.] // Blood. – 2004. – P. – 607 – 618.

328.Hofmeyr A., Slavin M.A. Emerging opportunistic yeast infections in haematology patients // Leuk. Lymphoma. – 2006. – Vol. 47, N 9. – P. 1736–1737.

329.International workshop on CLL. Chronic lymphocytic leukaemia: proposals for a revised prognostic staging system // British Journal of Haematology. – 1981. – Vol. 48. – P. 365–367.

296

330.International workshop on Chronic lymphocytic leukaemia

//Ann. Intern. Med. – 1989. – Vol. 110. – P. 236–237.

331.An overview of the Meropenem Yearly Susceptibility Test Information Collection (MYSTIC) Program: 1997–2004 / R.N. Jones [et al.] // Diagn. Infect. Dis. – 2005. – Vol. 53. – P. 247–256.

332.Kalil N., Cheson B.D. Management of Chronic lymphocyte leukemia // Drugs Aging. – 2000. – Vol. 16. – P. 9–27.

333.Chronic Lymphocytic Leukemia / D.P. Kantoyiannis [et al.]

//ed. B. D. Cheson. – N.Y. : M. Dekker, 1993.– Р. 399–412.

334.Kauczor H.U., Heussel C.P., Fischer B. Assessment of lung

171.– P. 1091–1096.

335.Keating M.J. Chronic lymphoproliferative disorders: chronic lymphocytic leukemia and hairy-cell leukemia // Curr. Opin. Oncol. – 1993. – Vol. 5, N 1. – P. 35–41.

336.Keating M.J., Manshouri T., O’Brien S. A high proportion of true complete remission can be obtained with a fludarabine, cyclophosphamide, rituximab combination (RFC) in chronic lymphocytic leukemia // Blood. – 2003. – Vol. 22. – P. 569.

337.Keating M.J., O’Brien S., Albitar M. Early results of a chemoimmunotherapy regimen of fludarabine, cyclophosphamide, and rituximab as initial therary for chronic lymphocytic leukemia // J. Clin. Oncol. – 2005. – Vol. 23. – P. 4079–4088.

338.Keats J.J., Reiman T., Maxwell C.A. In multiple myeloma, t (4; 14) (p16:q32) is an adverse is adverse prognostic factor irrespective of FGFR3 expression // Blood. – 2003. – P. – 1520 – 1529.

339.Kellogg D. L. In vivo mechanisms of cutaneous vasodilation and vasoconstriction in humans during thermoregulatory challenges // J. apl. Physiol. – 2006. – Vol. 100. – P. 1709–1718.

340.Kempf F., Capesing P., Mugel J.L. Un cas de calcinose pulmonaire au cours d’une myelomatose diffuse // J. Radiol. Electrol. –

1972. – Vol. 53, N 12. – P. 861–865.

341.Khouri I.F., Munsell M., Yajzi S. Comparable survival for nonablative and ablative alloggeneic transplantation for chronic lympho-

297

cytic leukemia: the case for early intervention // Blood. – 2000. – Vol.

96.– P. 205a.

342.Coronary blood flow after cold exposure and the effect of warmup exercise / H. K. Kim [et al.] // J. Am. Society Echocardiography.

– 2006. – Vol. 19, N 4. – P. 386–390.

343.Kohl F.V., Wicher P. Hochduch in lungenkreislaut Therapeutische Moglechakeiten // Thrapiewocye. – 1986. – Vol. 36, N 9. – P. 2024–2030.

344.Kotner L.M., Wang C.C. Plasmacytoma of the Upper Air and Food Passages // Cancer. – 1972. – Vol. 30, N 2. – P. 414–418.

345.Kraj M., Poglod R., Maj S. Comparative evaluation of safety and efficacy of pa-midronate and zoledronic acid in multiple myeloma patients (single center experience) // Acta Pol. Pharm. – 2002. – Vol. 59. – P. 478–482.

346.Kumar S., Fonseca R., Dispenzieri A. Prognostic value of angiogenesis in olitary bone plasmacytoma // Blood. – 2003. – Vol. 101.

– P. 1715–1717.

347.Kvandal P., Stefanovska A., Veber M. Regulation of human cutaneous circulation evaluated by laser Dopler flowmetry, iontophoresis, and spectral analysis: importance of nitric oxide and prostangladines // Mikrovaskular Research. – 2003. – Vol. 65. – P. 160 – 171.

348.Kyle R. A., Gertz M.A., Witzig T.E. Review of 1027 patients with newly diagnosed multiple myeloma // Mayo Clin. Proc. – 2003. – Vol. 78, N 1. – P. 21–33.

349.Laboratory investigations in clinical immunology: methods, pitfalls, and clinical indications. A second IUIS/WHO report // Clin. Immunol. Immunopathol. – 1988. – Vol. 49. – P. 478–497.

350.Risk factor and clinical features of nosocomial pneumonias / Yu. S. Landyshev [et al.] // IV Russia and China Medical Forum : abstracts. – Blagoveschensk, 2007. – P. 114–116.

351.Lebecque, P. Hysteresis of the alveolar capillary membrane in normal subjects // J. Appl. Physiol. – 1986. – Vol. 60, N 6. – P. 1442– 1445.

352.Lee C.K., Ma E.S., Shek T.W. Plasmablastic transformation of multiple myeloma // Hum. Pathol. – 2003. – Vol. 34, N 7. – P. 710–

353.Leporrier M., Chevret S., Casin B. Randomized comparison of fludarabine, CAP and CHOP in 938 previously untreated stage B and

298

C chronic lymphocytik leukemia patients // Blood. – 2001. – Vol. 98, N

8.– P. 2319–2325.

354.Levine R.A., Gibson T.S., Aretz T. Echocardiographic measurement of right ventricular volume // Circulation. – 1984. – Vol.

69.– P. 497–505.

355.Parapneumonic effusions / R.W. Light [et al.] // Amer. J. Med. – 1980. – Vol. 69. – P. 507–511.

356.Lim Y., Park S.R., Oh H.S. A case of primary plasmacytoma of lymph nodes // J. Intern. Med. – 2005. – Vol. 20, N 2. – P. 183–186.

357.Lindsley H., Teller D., Nonnan B. Hyperviscosity syndrome in multiple myeloma. A reversille, concentration – dependent aggregation of the myeloma protein // Amer. J. M. et al. – 1973. – Vol. 54, N 5. – P. 682–688.

358.Linet M. S., Blattner W.A. Chronic Lymphocyte Leukemia // Switz., 1988. – P. 11–15.

359.Lipton А., Small E., Saad F. he new bisphosphonate, Zometa (zoledronic acid), decreases skeletal complications in both osteolytic and osteoblastic lesion: a comparison to pamidronate // Cancer Invest. – 2002. – Vol. 20, Supl. 2. – P. 45–54.

360.Livermore D.M., Canton R., Gniadkowski M. X-M: changing the face of ESBLs in Europe // J. Antimicrob. Chemother. – 2007. – Vol. 59, N. 2. – P. 165–174.

361.Ma M.N., Yang H.H. Раrker he proteasome inhibitor PS –

341markedly enhances sensitivity of multiple myeloma tumor cells chemotherapeutic agents // Clin. Cancer Res – 2003. – P. – 1136 – 1144.

362.Maisnar V., Touskova M., Maly J. Importance of selected laboratory indicators in the differential diagnosis and monitoring of multiple myeloma // Vnitr. Lek. – 2002. – Vol. 48. – P. 209–297.

363.Menssen H.D., Sacalova A., Fontana A. Effects of long-term intravenous ibandronate therapy on skeletal-related events, survival, and bone resorption markers in patients with advanced multiple myeloma // J. Clin. Oncol. – 2002. – Vol. 20. – P. 2353–2359.

364.ligriti obstrukcio es az arteria pulmonalis hyomasa Kozotti osseufugyei terheles alatt / L. Meszaros [et al.] // Pneumol. hung. – 1983.

– Vol. 36, N 6. – P. 266–272.

365.Pulsed Doppler echocardiography in the diagnosis of pulmonary hypertension in COPD / M. Migueres [et al.] // Chest. – 1990. – Vol. 98, N 2. – P. 280–285.

299

366.Milkowski D.A., Worley B.D., Morris M.J. Richter's transformation presenting as an obstructing endobronchial lesion // Chest. – 1999. – Vol. 116, N 3. – P. 832–837.

367.Mitsiades N., Mitsiades C.D., Richardson P.G. The proteasome inhibitor PS-341 potentiates sensitivity of multiple myeloma cells to conventional chemotherapeutic agents: therapeutic applications // Blood. – 2003. – Vol. 101. – P. 2377–2380.

368.Mital O.P., Gupta D.K., Kansal H. M. Intrathoracic muelomatosis : a case report // Indian J. Chest. Dis. – 1974. – Vol. 16, N 2.

–P. 119–120.

369.Montserrat E. Chronic lymphoproliferative disorders // Curr. Opin. Oncol. – 1997. – Vol. 1. – P. 34–41.

370.Mozzaffari E., Mupparpu M., Otis L. Undiagnosed multiple myeloma causing extensite dental bleeding: report of a case and review // Oral Surg. Oral. Med. Oral. Radiol. Endod. – 2002. – Vol. 94. – P. 448– 453.

371.Muller N.L., Chiles C., Kullnig P. Pulmonary lymphongio- myomutosis-correlation CT with radiographic and functional findings // Radiology. – 1990. – Vol. 175. – P. 535–539.

372.Muller P.S., Terrell C.L., Gertz M.A. Fever of unknown origin caused by multiple myeloma: a report of 9 cases // Arch. Intern. Med. – 2002. – Vol. 162. – P. 1305–1309.

373.Murphy, T. F. The role of bacteria in airway in inflammation in exacerbations of chronic obstructive pulmonary disease. Pathogenesis and immune response // Cur. Opinion Infect. Dis. – 2006. – Vol. 19, N 3.

–P. 225–230.

374.Nagasava T., Abe T., Nakagava T. Pure red cell aplasia and hypogammaglobulinemia assotiated with T-cell CLL // Blood. – 1981. – Vol. 57, N 6. – P. 1025–1031.

375.Amsler S.C., Pearlman A.S., Janho G.S. Normal measurements by doppler echocardiography // 10 World Congress of Cardiology, Washington, 14-19 Sept. 1986. – Washington, 1986. – P. 274.

376.Nucci M., Anaissie E. Cutaneus infection by Fusarium species in healthy and immunocompromised hosts: implications for diagnosis and management // Clin. Infect. Dis. – 2002. – Vol. 35. – P. 909–920.

377.Oikonomou A., Muller N.L., Nantel S. Radiographic and high-resolution CT findings of influenza virus pneumonia in patients with

300